Samantha Marie Landino, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleus Accumbens | 2 | 2017 | 358 | 0.230 |
Why?
|
| Jaundice, Obstructive | 1 | 2020 | 22 | 0.180 |
Why?
|
| Self Stimulation | 2 | 2017 | 46 | 0.180 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2020 | 51 | 0.170 |
Why?
|
| Thymus Gland | 1 | 2024 | 1266 | 0.170 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 187 | 0.140 |
Why?
|
| Racemases and Epimerases | 1 | 2017 | 113 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 2539 | 0.130 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2017 | 287 | 0.130 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 362 | 0.130 |
Why?
|
| Dynorphins | 1 | 2015 | 82 | 0.120 |
Why?
|
| Cysts | 1 | 2020 | 685 | 0.120 |
Why?
|
| Social Behavior | 3 | 2019 | 1147 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2020 | 775 | 0.120 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2015 | 136 | 0.120 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 2188 | 0.110 |
Why?
|
| Nootropic Agents | 1 | 2015 | 159 | 0.110 |
Why?
|
| Immunity | 1 | 2019 | 1003 | 0.110 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 3837 | 0.100 |
Why?
|
| Cocaine | 1 | 2017 | 947 | 0.100 |
Why?
|
| Maternal Exposure | 1 | 2019 | 1096 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 903 | 0.100 |
Why?
|
| Mitral Valve | 1 | 2020 | 1475 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 1177 | 0.100 |
Why?
|
| Heart Transplantation | 1 | 2024 | 3301 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2019 | 1240 | 0.090 |
Why?
|
| Amygdala | 1 | 2018 | 1379 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2015 | 598 | 0.080 |
Why?
|
| Reoperation | 1 | 2020 | 4329 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 1566 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2019 | 2191 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1765 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2238 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 1434 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2819 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 3684 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 2257 | 0.050 |
Why?
|
| Hepatic Duct, Common | 1 | 2020 | 48 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 4423 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2015 | 4530 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2019 | 1862 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2017 | 6983 | 0.040 |
Why?
|
| Cholecystectomy | 1 | 2020 | 408 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2024 | 2363 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 24318 | 0.040 |
Why?
|
| Microdialysis | 1 | 2017 | 156 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 7073 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15833 | 0.030 |
Why?
|
| Dominance-Subordination | 1 | 2015 | 26 | 0.030 |
Why?
|
| Sex Factors | 2 | 2020 | 10632 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2020 | 5349 | 0.030 |
Why?
|
| Interferon Inducers | 1 | 2014 | 24 | 0.030 |
Why?
|
| Animals | 7 | 2024 | 169285 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1755 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 831 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39354 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 417 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2015 | 643 | 0.030 |
Why?
|
| Interneurons | 1 | 2018 | 591 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18349 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1793 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2019 | 9384 | 0.020 |
Why?
|
| Time Factors | 3 | 2019 | 40220 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2017 | 1191 | 0.020 |
Why?
|
| Male | 8 | 2024 | 364731 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 1141 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14488 | 0.020 |
Why?
|
| Brain | 2 | 2015 | 27362 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1892 | 0.020 |
Why?
|
| Encephalitis | 1 | 2014 | 441 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2020 | 81760 | 0.020 |
Why?
|
| Dopamine | 1 | 2017 | 1592 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2222 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 22380 | 0.020 |
Why?
|
| Resilience, Psychological | 1 | 2015 | 807 | 0.020 |
Why?
|
| Mice | 3 | 2019 | 82049 | 0.020 |
Why?
|
| Echocardiography | 1 | 2020 | 5047 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7601 | 0.020 |
Why?
|
| Pregnancy | 2 | 2019 | 30255 | 0.020 |
Why?
|
| Aged | 4 | 2020 | 171502 | 0.020 |
Why?
|
| Female | 6 | 2020 | 397187 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8890 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12840 | 0.020 |
Why?
|
| Middle Aged | 4 | 2020 | 223487 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1810 | 0.020 |
Why?
|
| Acute Disease | 1 | 2015 | 7243 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 59626 | 0.010 |
Why?
|
| Cytokines | 1 | 2019 | 7452 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2015 | 3117 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10590 | 0.010 |
Why?
|
| Risk Factors | 2 | 2020 | 74944 | 0.010 |
Why?
|
| Humans | 7 | 2020 | 768171 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12801 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21538 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 9514 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 10873 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 60066 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65379 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 89169 | 0.010 |
Why?
|
| United States | 1 | 2019 | 73039 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 223646 | 0.000 |
Why?
|